Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
With a strengthening commercial business, ELV is seeing steady membership growth.
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective.
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an Elevance spokeswoman said.
5 Stocks With Above-Market Yields Just Raised Payments Further
With the stock market going through its first earnings season of 2025, companies are making important announcements. This includes the approval of share buyback programs, as well as dividend increases.
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes.
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership partially offset the positives.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage unit. It also raised its dividend.
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
On Thursday, Elevance Health Inc. ELV reported fourth-quarter revenues of $44.99 billion, up 6% year-over-year, slightly higher than the consensus of $44.86 billion.
